Generated by AI
ResMed Inc. is a healthcare company that develops and supplies digital health technologies and cloud-connected medical devices for respiratory care. Its core products support the treatment of sleep apnea, COPD, and other chronic diseases through flow generators, masks, and related accessories used in home-based and clinical settings. ResMed also provides software and data platforms that help clinicians, patients, and care providers monitor therapy and manage ongoing treatment more effectively. The company serves healthcare systems, medical professionals, and patients across multiple regions, with a strong presence in the Americas as well as Europe, Japan, and Australia. Headquartered in San Diego, California, ResMed plays an important role in the medical instruments and supplies market by combining device-based therapy with connected digital care solutions.
Website9001 Spectrum Center Boulevard
San Diego, CA, 92123
United States
The latest articles about RMD.
Tipranks Press Release.
ResMed, whose devices treat sleep apnea, has dropped on unfounded concerns that weight-loss drugs will replace its treatment. The stock is cheap and worth buying at current prices.
Summary of Oct 30's posts. Generated by AI.
Summary of Oct 15's posts. Generated by AI.
ResMed is a Hold, valuation offers a low margin of safety despite strong long-term fundamentals and recurring revenue streams. Read more on RMD stock here.
Summary of Jan 24's posts. Generated by AI.
Summary of Oct 21's posts. Generated by AI.
Investors talking about RMD also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.